Literature DB >> 12070122

Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis.

Peter Sinnaeve1, Jean-Daniel Chiche, Hilde Gillijns, Natascha Van Pelt, Douglas Wirthlin, Frans Van De Werf, Desire Collen, Kenneth D Bloch, Stefan Janssens.   

Abstract

BACKGROUND: Neointima formation after arterial injury is associated with reduced vascular cyclic guanosine monophosphate (cGMP) and cGMP-dependent protein kinase (PKG), a major cGMP effector in vascular smooth muscle. We tested the effect of PKG overexpression on the neointimal response to vascular injury. Methods and Results- Infection of cultured rat aortic smooth muscle cells (RASMCs) with an adenoviral vector specifying a cGMP-independent, constitutively active PKG mutant (AdPKGcat) reduced serum-induced migration by 33% and increased serum-deprivation-induced apoptosis 2-fold (P<0.05 for both). Infection with wild-type PKG (AdPKG), in the absence of cGMP, did not affect migration or apoptosis. Two weeks after balloon-injured rat carotid arteries were infected with 1x 10(10) pfu AdPKGcat (n=12), AdPKG (n=8), or a control adenovirus (n=8), intima-to-media ratio was less in AdPKGcat-infected arteries than in AdPKG- or control adenovirus-infected vessels (0.26+/-0.06 versus 0.61+/-0.12 and 0.70+/-0.12, respectively, P<0.05 for both). Two weeks after intramural administration of 1.75x10(10) pfu AdPKGcat (n=8) or a control adenovirus (n=8) into porcine coronary arteries with in-stent restenosis, luminal diameter was greater in AdPKGcat-infected arteries than in control adenovirus-infected vessels (2.32+/-0.16 versus 1.81+/-0.13 mm, P=0.028), associated with reduced neointimal area (3.30+/-0.24 versus 4.15+/-0.13 mm(2), P=0.008), neointima-to-vessel area ratio (0.42+/-0.05 versus 0.58+/-0.04, P<0.05), and percent stenosis (45+/-6% versus 70+/-4%, P<0.05).
CONCLUSIONS: Expression of a constitutively active PKG reduces neointima formation after balloon injury in rats and reduces coronary in-stent restenosis in pigs. PKGcat gene transfer may be a promising strategy for vasculoproliferative disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070122     DOI: 10.1161/01.cir.0000018169.59205.ca

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

1.  Regulation of vascular smooth muscle cell growth: targeting the final common pathway.

Authors:  Angela M Taylor; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-01       Impact factor: 8.311

2.  Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice.

Authors:  Yannis Hara; Yassine Sassi; Christelle Guibert; Natacha Gambaryan; Peter Dorfmüller; Saadia Eddahibi; Anne-Marie Lompré; Marc Humbert; Jean-Sébastien Hulot
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

3.  Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation.

Authors:  Andrew W Holt; Danielle N Martin; Patti R Shaver; Shaquria P Adderley; Joshua D Stone; Chintamani N Joshi; Jake T Francisco; Robert M Lust; Douglas A Weidner; Brian M Shewchuk; David A Tulis
Journal:  Cell Signal       Date:  2016-06-11       Impact factor: 4.315

4.  Protein kinase G signaling disrupts Rac1-dependent focal adhesion assembly in liver specific pericytes.

Authors:  Chittaranjan Routray; Chunsheng Liu; Usman Yaqoob; Daniel D Billadeau; Kenneth D Bloch; Kozo Kaibuchi; Vijay H Shah; Ningling Kang
Journal:  Am J Physiol Cell Physiol       Date:  2011-03-30       Impact factor: 4.249

Review 5.  Applied gene therapy in preclinical models of vascular injury.

Authors:  Stefan P Janssens
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

6.  Stainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosis.

Authors:  Manuel A Pallero; Melissa Talbert Roden; Yiu-Fai Chen; Peter G Anderson; Jack Lemons; Brigitta C Brott; Joanne E Murphy-Ullrich
Journal:  J Vasc Res       Date:  2009-12-16       Impact factor: 1.934

7.  cGMP-dependent protein kinase I gamma encodes a nuclear localization signal that regulates nuclear compartmentation and function.

Authors:  Jingsi Chen; Jesse D Roberts
Journal:  Cell Signal       Date:  2014-08-27       Impact factor: 4.315

8.  Cyclic guanosine monophosphate-dependent protein kinase I promotes adhesion of primary vascular smooth muscle cells.

Authors:  Pascal Weinmeister; Robert Lukowski; Stefan Linder; Claudia Traidl-Hoffmann; Ludger Hengst; Franz Hofmann; Robert Feil
Journal:  Mol Biol Cell       Date:  2008-08-06       Impact factor: 4.138

9.  Proteolytic processing of cGMP-dependent protein kinase I mediates nuclear cGMP signaling in vascular smooth muscle cells.

Authors:  Takahiro Sugiura; Hidehiko Nakanishi; Jesse D Roberts
Journal:  Circ Res       Date:  2008-06-05       Impact factor: 17.367

10.  Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis.

Authors:  Robert Lukowski; Pascal Weinmeister; Dominik Bernhard; Susanne Feil; Michael Gotthardt; Joachim Herz; Steffen Massberg; Alma Zernecke; Christian Weber; Franz Hofmann; Robert Feil
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-17       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.